Placental and umbilical cord blood derived mesenchymal cell for regenerative medicine and construction of a banking system for mesenchymal cell.
用于再生医学的胎盘和脐带血来源的间充质细胞以及间充质细胞库系统的构建。
基本信息
- 批准号:16390429
- 负责人:
- 金额:$ 8.83万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We examined the possibility whether human placenta and cord blood can be a new cell source for regenerative medicine utilizing the bank system that has been established in our laboratory. First, fibroblast-like cells from fetal and maternal part were isolated by an explant method. The cells derived from fetal part were without contamination with maternal cells. Since the information required for cord blood transplantation, such as HLA typing of infant, viral and bacterial contamination in cord blood units, family history of the donor etc, were recorded in the bank, we chose chorionic villi from the fetal part as the source of mesenchymal cells in this study. The cells derived from chorionic villi (human placenta derived mesenchymal stem cells: hPDMSCs) were cultured with DMEM+10%FBS. The phenotypes of those cells were similar to those derived from bone marrow and adipose tissue; positive expression of CD29, CD44, CD73, CD105, CD90, HLA-class I, but negative for CD31, CD34, CD45,TIE-II … More and HLA-class II antigen. The hPDMSCs could differentiate to osteoblast in the osteogenic induction condition. For chondrogenic differentiation, a pellet culture system was used. The size of the pellet increased with glistening and transparency during the induction culture, and toluidine blue staining and type-II collagen immuno-histochemical staining were positive in paraffin section of the pellets. Differentiation ability to adipocyte and neural-like cell were also confirmed in the cells. The chondrogenesis of hPDMCs was also detected in vivo by transplantation of induced cells in a scaffold at subcutaneous and osteochondral defected knee of nude mice and rat.We attempted to prolong the life span of hPDMCs by transduction with hTERT and Bmi-1 using lenti-vector, the immortalized cells kept the differentiation potential into osteogenic, chondrogenic, adipogenic cells.Then we established the method for isolation of mesenchymal cell from cord blood (CB). The success rate of isolation of mesenchymal cell from CB increased up to 70% when the volume of CB was more than 60ml and the time between deliveries and cell isolation was shorter than 5 hours. Those cells showed high osteogenic, chondrogenic differentiation, but low for adipogenesis. The osteogenesis and chondrogensis were also observed in vivo using nude mice and rat. Thus our results indicated that human placenta and umbilical cord blood can be allogeneic mesenchymal stem cell sources for regenerative medicine. Less
我们利用我们实验室建立的数据库系统,研究了人胎盘和脐带血是否可以成为再生医学的新细胞来源。首先,采用组织块法分离胎儿和母体组织中的成纤维细胞。取自胎儿的细胞与母体细胞无污染。由于脐血移植所需的资料,如婴儿的人类白细胞抗原配型、脐带血中的病毒和细菌污染、供者的家族史等,我们选择了胎儿部分的绒毛作为间充质细胞的来源。取人胎盘间充质干细胞(HPDMSCs),用DMEM+10%胎牛血清培养。CD29、CD44、CD73、CD105、CD90、HLAI类细胞表达阳性,CD31、CD34、CD45、Tie-II…表达阴性More和HLAII类抗原。在成骨诱导条件下,hPDMSCs可向成骨细胞分化。在软骨分化方面,使用颗粒培养系统。诱导培养过程中,颗粒体积增大,光亮透明,石蜡切片甲苯胺蓝染色和II型胶原免疫组织化学染色均为阳性。细胞向脂肪细胞和神经样细胞分化的能力也得到证实。将诱导后的细胞移植到裸鼠和大鼠的皮下和骨软骨缺损处,观察其在体内的成软骨作用。我们尝试通过Lenti载体转导hTERT和Bmi-1来延长hPDMCs的寿命,永生化细胞保持了向成骨、成软骨、成脂细胞分化的潜能。当脐带血的体积大于60ml时,从脐带血中分离间充质细胞的成功率可达70%,且从分娩到细胞分离的时间小于5h。这些细胞表现出高度的成骨、成软骨分化,但成脂能力较低。在裸鼠和大鼠体内观察其成骨和成软骨情况。因此,我们的结果表明,人胎盘和脐带血可以作为再生医学的同种异体间充质干细胞来源。较少
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering.
- DOI:10.1016/j.bbrc.2005.12.091
- 发表时间:2006-02
- 期刊:
- 影响因子:3.1
- 作者:Xiaohong Zhang;A. Mitsuru;K. Igura;Kenji Takahashi;S. Ichinose;Satoru Yamaguchi;Tsuneo A. Takahashi
- 通讯作者:Xiaohong Zhang;A. Mitsuru;K. Igura;Kenji Takahashi;S. Ichinose;Satoru Yamaguchi;Tsuneo A. Takahashi
「研究成果報告書概要(和文)」より
摘自《研究结果报告摘要(日文)》
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Kawauchi;et. al.;Nishimura et al.;Dezawa et al.;Yoshizawa et al.;星野 幹雄;星野 幹雄
- 通讯作者:星野 幹雄
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAKAHASHI Tsuneo其他文献
TAKAHASHI Tsuneo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAKAHASHI Tsuneo', 18)}}的其他基金
The study on role of TGF β in estrogen-induced endometrial carcinoma
TGFβ在雌激素诱发子宫内膜癌中作用的研究
- 批准号:
12671621 - 财政年份:2000
- 资助金额:
$ 8.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The study on mechanism for regulation of interaction between human decidua and villi.
人体蜕膜与绒毛相互作用调控机制的研究。
- 批准号:
09470364 - 财政年份:1997
- 资助金额:
$ 8.83万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The study on the Izumozaki-carpenters in Echigo and the activities of the Edo and the Meiji periods
越后出云崎木匠及其江户、明治时期的活动研究
- 批准号:
07650745 - 财政年份:1995
- 资助金额:
$ 8.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of EGF and TGFalpha-EFGR in estrogen effect on endometrial cancinogenesis.
EGF 和 TGFα-EFGR 在雌激素对子宫内膜癌变的影响中的作用。
- 批准号:
06671673 - 财政年份:1994
- 资助金额:
$ 8.83万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Histochemical and Ultrastructural Studies on Relationship between Initial Calcification and Lipids
初始钙化与脂质关系的组织化学和超微结构研究
- 批准号:
05671524 - 财政年份:1993
- 资助金额:
$ 8.83万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Ultrastractural Studies on interrelationship between initial
初始之间相互关系的超结构研究
- 批准号:
01571001 - 财政年份:1989
- 资助金额:
$ 8.83万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Development and Validation of a Combined Risk Prediction Model for Childhood Obesity Using Cord Blood Genomics and Epigenomics
利用脐带血基因组学和表观基因组学开发和验证儿童肥胖联合风险预测模型
- 批准号:
23H02880 - 财政年份:2023
- 资助金额:
$ 8.83万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Efficacy of Transmaternal Human Cord Blood Cell Transplantation Therapy for Fetal Tissue Damage Caused by Ischemia-Reperfusion
经母体人脐带血细胞移植治疗缺血再灌注引起的胎儿组织损伤的疗效
- 批准号:
23K07314 - 财政年份:2023
- 资助金额:
$ 8.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Project 4: Off-the-shelf engineered cord blood-derived natural killer cells for the treatment acute lymphoblastic leukemia
项目 4:现成的工程化脐带血自然杀伤细胞,用于治疗急性淋巴细胞白血病
- 批准号:
10931069 - 财政年份:2023
- 资助金额:
$ 8.83万 - 项目类别:
Validation of biomarkers predicting clinical outcomes of umbilical cord blood transplantation
预测脐带血移植临床结果的生物标志物的验证
- 批准号:
MR/W029669/1 - 财政年份:2023
- 资助金额:
$ 8.83万 - 项目类别:
Research Grant
Cell therapy research using human umbilical cord blood-derived hemangioblast-like cells for the treatment of cerebral infarction
人脐带血成血管样细胞治疗脑梗塞的细胞治疗研究
- 批准号:
22K09221 - 财政年份:2022
- 资助金额:
$ 8.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cord Blood Adductomics in Bronchopulmonary Dysplasia
支气管肺发育不良的脐带血加合物组学
- 批准号:
10580523 - 财政年份:2022
- 资助金额:
$ 8.83万 - 项目类别:
Optimization of small molecule integrin activators to enhance cord blood transplant
优化小分子整合素激活剂以增强脐带血移植
- 批准号:
10573229 - 财政年份:2022
- 资助金额:
$ 8.83万 - 项目类别:
Optimization of small molecule integrin activators to enhance cord blood transplant
优化小分子整合素激活剂以增强脐带血移植
- 批准号:
10368757 - 财政年份:2022
- 资助金额:
$ 8.83万 - 项目类别:
Unveil the regulatory functions of cord blood in the therapeutic mechanism of cord blood transfusion against cerebral palsy
揭示脐带血在脑瘫输注治疗机制中的调节功能
- 批准号:
21K07846 - 财政年份:2021
- 资助金额:
$ 8.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-target analysis of maternal and cord blood samples: Advancing computational tools and discovering novel chemicals
母体和脐带血样本的非目标分析:改进计算工具并发现新型化学物质
- 批准号:
10191991 - 财政年份:2021
- 资助金额:
$ 8.83万 - 项目类别:














{{item.name}}会员




